2025 · 3rd Quarter (July 1 - Sep 30)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by YC CONSULTING, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 21, 2025
Income: $30,000.00
Expenses: Not reported
Registrant: YC CONSULTING, LLC
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Filing UUID: 6eadc4df-720e-49e0-89b3-94b98018c39d
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 1, One Big Beautiful Bill Act - healthcare provisions Prescription Drug Pricing Policy

Literal federal measure citations: H.R. 1492, H.R. 1

TRD · Trade (domestic/foreign)

Tariff policy issues

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.